AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
DOES TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) CONTRIBUTE TO MYOCARDIALREPERFUSION INJURY IN ANESTHETIZED RATS
Authors: MCVEY M PERRONE MH CLARK KL
Citation: M. Mcvey et al., DOES TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) CONTRIBUTE TO MYOCARDIALREPERFUSION INJURY IN ANESTHETIZED RATS, General pharmacology, 32(1), 1999, pp. 41-45
INHIBITION OF REPETITIVE THROMBUS FORMATION IN THE STENOSED CANINE CORONARY-ARTERY BY ENOXAPARIN, BUT NOT BY UNFRACTIONATED HEPARIN
Authors: LEADLEY RJ KASIEWSKI CJ BOSTWICK JS BENTLEY R DUNWIDDIE CT PERRONE MH
Citation: Rj. Leadley et al., INHIBITION OF REPETITIVE THROMBUS FORMATION IN THE STENOSED CANINE CORONARY-ARTERY BY ENOXAPARIN, BUT NOT BY UNFRACTIONATED HEPARIN, Arteriosclerosis, thrombosis, and vascular biology, 18(6), 1998, pp. 908-914
CARDIOPROTECTIVE EFFECTS OF THE NOVEL ADENOSINE A(1) A(2) RECEPTOR AGONIST, AMP-579/
Authors: MCVEY M SMITS GJ COX BF PERRONE MH CLARK KL
Citation: M. Mcvey et al., CARDIOPROTECTIVE EFFECTS OF THE NOVEL ADENOSINE A(1) A(2) RECEPTOR AGONIST, AMP-579/, The FASEB journal, 12(4), 1998, pp. 452-452
PHARMACOLOGICAL CHARACTERIZATION OF AMP579, A NOVEL A(1) A(2) ADENOSINE RECEPTOR AGONIST AND CARDIOPROTECTIVE/
Authors: MERKEL L HAWKINS ED COLUSSI DJ ROSSI D ROJAS CJ HAMEL LT JARVIS MF FINK C STUDT RW SPADA AP CLARK KL PERRONE MH
Citation: L. Merkel et al., PHARMACOLOGICAL CHARACTERIZATION OF AMP579, A NOVEL A(1) A(2) ADENOSINE RECEPTOR AGONIST AND CARDIOPROTECTIVE/, The FASEB journal, 12(4), 1998, pp. 453-453
CARDIOPROTECTIVE EFFECTS OF THE NOVEL ADENOSINE-A(1) ADENOSINE-A(2) RECEPTOR AGONIST AMP-579 IN A PORCINE MODEL OF MYOCARDIAL-INFARCTION
Authors: SMITS GJ MCVEY M COX BF PERRONE MH CLARK KL
Citation: Gj. Smits et al., CARDIOPROTECTIVE EFFECTS OF THE NOVEL ADENOSINE-A(1) ADENOSINE-A(2) RECEPTOR AGONIST AMP-579 IN A PORCINE MODEL OF MYOCARDIAL-INFARCTION, The Journal of pharmacology and experimental therapeutics, 286(2), 1998, pp. 611-618
IDENTIFICATION AND INITIAL STRUCTURE-ACTIVITY-RELATIONSHIPS OF A NOVEL CLASS OF NONPEPTIDE INHIBITORS OF BLOOD-COAGULATION FACTOR XA
Authors: KLEIN SI CZEKAJ M GARDNER CJ GUERTIN KR CHENEY DL SPADA AP BOLTON SA BROWN K COLUSSI D HERAN CL MORGAN SR LEADLEY RJ DUNWIDDIE CT PERRONE MH CHU V
Citation: Si. Klein et al., IDENTIFICATION AND INITIAL STRUCTURE-ACTIVITY-RELATIONSHIPS OF A NOVEL CLASS OF NONPEPTIDE INHIBITORS OF BLOOD-COAGULATION FACTOR XA, Journal of medicinal chemistry, 41(4), 1998, pp. 437-450
THE RELATIONSHIP BETWEEN HYPERTROPHY AND APOPTOSIS IN CULTURED NEONATAL VENTRICULAR MYOCYTES
Authors: ZHU H QI M MCELWEEWITMER SA MERKELJORDAN L PERRONE MH CLARK KL ZILBERSTEIN A
Citation: H. Zhu et al., THE RELATIONSHIP BETWEEN HYPERTROPHY AND APOPTOSIS IN CULTURED NEONATAL VENTRICULAR MYOCYTES, Circulation, 98(17), 1998, pp. 1815-1815
COMPARISON OF ENOXAPARIN, HIRULOG, AND HEPARIN AS ADJUNCTIVE ANTITHROMBOTIC THERAPY DURING THROMBOLYSIS WITH RTPA IN THE STENOSED CANINE CORONARY-ARTERY
Authors: LEADLEY RJ KASIEWSKI CJ BOSTWICK JS BENTLEY R MCVEY MJ WHITE FJ PERRONE MH DUNWIDDIE CT
Citation: Rj. Leadley et al., COMPARISON OF ENOXAPARIN, HIRULOG, AND HEPARIN AS ADJUNCTIVE ANTITHROMBOTIC THERAPY DURING THROMBOLYSIS WITH RTPA IN THE STENOSED CANINE CORONARY-ARTERY, Thrombosis and haemostasis, 78(4), 1997, pp. 1278-1285
CARDIOVASCULAR AND METABOLIC EFFECTS OF ADENOSINE A(1)-RECEPTOR AGONISTS IN STREPTOZOTOCIN-TREATED RATS
Authors: COX BF CLARK KL PERRONE MH WELZEL GE GREENLAND BD COLUSSI DJ MERKEL LA
Citation: Bf. Cox et al., CARDIOVASCULAR AND METABOLIC EFFECTS OF ADENOSINE A(1)-RECEPTOR AGONISTS IN STREPTOZOTOCIN-TREATED RATS, Journal of cardiovascular pharmacology, 29(3), 1997, pp. 417-426
REGIONAL HEMODYNAMIC DOSE-RESPONSE OF LEMAKALIM AND GLYBENCLAMIDE IN ANESTHETIZED RATS
Authors: SMITS GJ PERRONE MH COX BF
Citation: Gj. Smits et al., REGIONAL HEMODYNAMIC DOSE-RESPONSE OF LEMAKALIM AND GLYBENCLAMIDE IN ANESTHETIZED RATS, Journal of cardiovascular pharmacology, 29(1), 1997, pp. 49-56
RPR-107393, A POTENT SQUALENE SYNTHASE INHIBITOR AND ORALLY EFFECTIVECHOLESTEROL-LOWERING AGENT - COMPARISON WITH INHIBITORS OF HMG-COA REDUCTASE
Authors: AMIN D RUTLEDGE RZ NEEDLE SN GALCZENSKI HF NEUENSCHWANDER K SCOTESE AC MAGUIRE MP BUSH RC HELE DJ BILDER GE PERRONE MH
Citation: D. Amin et al., RPR-107393, A POTENT SQUALENE SYNTHASE INHIBITOR AND ORALLY EFFECTIVECHOLESTEROL-LOWERING AGENT - COMPARISON WITH INHIBITORS OF HMG-COA REDUCTASE, The Journal of pharmacology and experimental therapeutics, 281(2), 1997, pp. 746-752
MECHANISMS INVOLVED IN VENTRICULAR HYPERTROPHY - ROLE OF P2X, P2Y, AND ENDOTHELIN RECEPTORS
Authors: COX BF CLARK KL WELZEL GE GREENLAND BD ROACH AG VALERIO MG STANKUS GP PERRONE MH
Citation: Bf. Cox et al., MECHANISMS INVOLVED IN VENTRICULAR HYPERTROPHY - ROLE OF P2X, P2Y, AND ENDOTHELIN RECEPTORS, The FASEB journal, 10(3), 1996, pp. 1784-1784
ANTITHROMBOTIC ACTIVITY OF RG13965, A NOVEL PLATELET FIBRINOGEN RECEPTOR ANTAGONIST
Authors: BOSTWICK JS KASIEWSKI CJ CHU V KLEIN SI SABATINO RD PERRONE MH DUNWIDDIE CT COOK JJ LEADLEY RJ
Citation: Js. Bostwick et al., ANTITHROMBOTIC ACTIVITY OF RG13965, A NOVEL PLATELET FIBRINOGEN RECEPTOR ANTAGONIST, Thrombosis research, 82(6), 1996, pp. 495-507
RPR101821, A NEW POTENT CHOLESTEROL-LOWERING AGENT - INHIBITION OF SQUALENE SYNTHASE AND 7-DEHYDROCHOLESTEROL REDUCTASE
Authors: AMIN D RUTLEDGE RZ NEEDLE SJ HELE DJ NEUENSWANDER K BUSH RC BILDER GE PERRONE MH
Citation: D. Amin et al., RPR101821, A NEW POTENT CHOLESTEROL-LOWERING AGENT - INHIBITION OF SQUALENE SYNTHASE AND 7-DEHYDROCHOLESTEROL REDUCTASE, Naunyn-Schmiedeberg's archives of pharmacology, 353(2), 1996, pp. 233-240
-(METHYLPENTYLAMINO)-PROPYLIDENE-1,1-BISPHOSPHONIC ACID AS A POTENT INHIBITOR OF SQUALENE SYNTHASE
Authors: AMIN D CORNELL SA PERRONE MH BILDER GE
Citation: D. Amin et al., -(METHYLPENTYLAMINO)-PROPYLIDENE-1,1-BISPHOSPHONIC ACID AS A POTENT INHIBITOR OF SQUALENE SYNTHASE, Arzneimittel-Forschung, 46(8), 1996, pp. 759-762
IN-VITRO LIPOLYSIS IN NORMAL AND DIABETIC RATS - EFFECT OF ADENOSINE AGONISTS
Authors: MERKEL L COLUSSI DJ LEWIS DF ROJAS CJ PERRONE MH
Citation: L. Merkel et al., IN-VITRO LIPOLYSIS IN NORMAL AND DIABETIC RATS - EFFECT OF ADENOSINE AGONISTS, The FASEB journal, 9(4), 1995, pp. 750-750
CARDIOVASCULAR AND ANTILIPOLYTIC EFFECTS OF A1 SELECTIVE ADENOSINE AGONISTS IN TELEMETRY INSTRUMENTED DIABETIC RATS
Authors: GREENLAND BD WELZEL GE PERRONE MH COX BF
Citation: Bd. Greenland et al., CARDIOVASCULAR AND ANTILIPOLYTIC EFFECTS OF A1 SELECTIVE ADENOSINE AGONISTS IN TELEMETRY INSTRUMENTED DIABETIC RATS, The FASEB journal, 9(3), 1995, pp. 121-121
EFFECTS OF THE A1 SELECTIVE AGONIST GR79236 AND THE A1 A3 AGONIST APNEA ON MYOCARDIAL-FUNCTION AND HEMODYNAMICS IN THE DOG/
Authors: COX BF PERRONE MH GREENLAND BD
Citation: Bf. Cox et al., EFFECTS OF THE A1 SELECTIVE AGONIST GR79236 AND THE A1 A3 AGONIST APNEA ON MYOCARDIAL-FUNCTION AND HEMODYNAMICS IN THE DOG/, The FASEB journal, 9(3), 1995, pp. 121-121
CHARACTERIZATION AND INHIBITION OF 15-LIPOXYGENASE IN HUMAN MONOCYTES- COMPARISON WITH SOYBEAN 15-LIPOXYGENASE
Authors: GLEASON MM ROJAS CJ LEARN KS PERRONE MH BILDER GE
Citation: Mm. Gleason et al., CHARACTERIZATION AND INHIBITION OF 15-LIPOXYGENASE IN HUMAN MONOCYTES- COMPARISON WITH SOYBEAN 15-LIPOXYGENASE, American journal of physiology. Cell physiology, 37(5), 1995, pp. 1301-1307
CARDIOVASCULAR AND ANTILIPOLYTIC EFFECTS OF THE ADENOSINE AGONIST GR79236
Authors: MERKEL LA HAWKINS ED COLUSSI DJ GREENLAND BD SMITS GJ PERRONE MH COX BF
Citation: La. Merkel et al., CARDIOVASCULAR AND ANTILIPOLYTIC EFFECTS OF THE ADENOSINE AGONIST GR79236, Pharmacology, 51(4), 1995, pp. 224-236
ANTITHROMBOTIC ACTIVITY OF RPR110173, AN ORALLY-ACTIVE PLATELET FIBRINOGEN RECEPTOR ANTAGONIST, IN CANINE MODELS OF ARTERIAL THROMBOSIS
Authors: LEADLEY RJ BOSTWICK JS KASIEWSKI CJ CHU V KLEIN SI CZEKAJ M GARDNER CJ PERRONE MH DUNWIDDIE CT
Citation: Rj. Leadley et al., ANTITHROMBOTIC ACTIVITY OF RPR110173, AN ORALLY-ACTIVE PLATELET FIBRINOGEN RECEPTOR ANTAGONIST, IN CANINE MODELS OF ARTERIAL THROMBOSIS, Circulation, 92(8), 1995, pp. 2329-2329
IN-VITRO CHARACTERIZATION OF A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST -RPR-110173
Authors: CHU V SABATINO RD KLEIN SI BIECHY KD LEADLEY RJ BOSTWICK JS KASIEWSKI CJ PERRONE MH DUNWIDDIE CT
Citation: V. Chu et al., IN-VITRO CHARACTERIZATION OF A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST -RPR-110173, Blood, 86(10), 1995, pp. 352-352
ISCHEMIA-REPERFUSION SELECTIVELY ATTENUATES CORONARY VASODILATATION TO AN ADENOSINE A(2)-AGONIST BUT NOT TO AN A(1)-AGONIST IN THE DOG
Authors: COX BF GREENLAND BD PERRONE MH MERKEL LA
Citation: Bf. Cox et al., ISCHEMIA-REPERFUSION SELECTIVELY ATTENUATES CORONARY VASODILATATION TO AN ADENOSINE A(2)-AGONIST BUT NOT TO AN A(1)-AGONIST IN THE DOG, British Journal of Pharmacology, 111(4), 1994, pp. 1233-1239
PDGF-RECEPTOR PROTEIN-TYROSINE KINASE-ACTIVITY IN CAROTID-ARTERY IS ENHANCED BY INJURY AND INHIBITED INVIVO BY TYRPHOSTIN RG 13291
Authors: BILDER GE KASIEWSKI CJ WALCZAK EM PERRONE MH
Citation: Ge. Bilder et al., PDGF-RECEPTOR PROTEIN-TYROSINE KINASE-ACTIVITY IN CAROTID-ARTERY IS ENHANCED BY INJURY AND INHIBITED INVIVO BY TYRPHOSTIN RG 13291, Drug development research, 29(2), 1993, pp. 158-166
ANGIOTENSIN SUBTYPE-1 BLOCKADE SELECTIVELY POTENTIATES ADENOSINE SUBTYPE 2-MEDIATED VASODILATION
Authors: SMITS GJ KITZEN JM PERRONE MH COX BF
Citation: Gj. Smits et al., ANGIOTENSIN SUBTYPE-1 BLOCKADE SELECTIVELY POTENTIATES ADENOSINE SUBTYPE 2-MEDIATED VASODILATION, Hypertension, 22(2), 1993, pp. 221-230
Risultati: 1-25 | 26-29